• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳糜泻患者、其家族成员及普通人群中HLA DQ2和DQ8的患病率。

The prevalence of HLA DQ2 and DQ8 in patients with celiac disease, in family and in general population.

作者信息

Cecilio Lucila Arantes, Bonatto Mauro W

机构信息

School of Medicine, Faculdade Assis Gurgacz, Cascavel, PR, Brazil.

aff1, Brazil.

出版信息

Arq Bras Cir Dig. 2015 Jul-Sep;28(3):183-5. doi: 10.1590/S0102-67202015000300009.

DOI:10.1590/S0102-67202015000300009
PMID:26537142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4737358/
Abstract

BACKGROUND

Celiac disease is an enteropathy characterized by gluten sensitivity and broad clinical aspect. Has a multifactorial cause and depends on genetic, immunological and environmental factors for its development. The genetic influence is given mostly by the human leukocyte antigens HLA DQ2 and DQ8.

AIM

To evaluate the prevalence of human leukocyte antigens DQ2 and DQ8 in three different groups: patients with celiac disease, first-degree relatives and the general population.

METHOD

Retrospective analysis that evaluated serologic and endoscopic data of 74 patients with celiac disease and 109 non-celiac, which were subdivided into two subgroups: non-celiac who had first-degree relatives with celiac and non-celiac who did not. All patients underwent laboratory examination for screening genetic sensitivity given by HLA DQ2 and HLA DQ8 by.

RESULTS

The presence of HLA DQ2 and DQ8 was identified in 98,4% of 74 celiac patients, of which 79,7% had only HLA DQ2; 8,1% had only HLA DQ8 and 10,8% had both antigens histocompatibility. In the group of relatives of celiac patients, were included 29 patients; among them, 89,6% had HLA DQ2 and/or DQ8; 76% only the HLA DQ2, 10,3% only HLA DQ8 and 3,4% presented both human leukocyte antigens (HLA).

CONCLUSION

HLA DQ2/DQ8 was present in 98,4% of celiac patients; 89,6% relatives of celiac family and in 55,4% of people from the general population without family celiac.

摘要

背景

乳糜泻是一种以麸质敏感性和广泛临床症状为特征的肠病。其病因是多因素的,发展取决于遗传、免疫和环境因素。遗传影响主要由人类白细胞抗原HLA DQ2和DQ8决定。

目的

评估人类白细胞抗原DQ2和DQ8在三个不同组中的患病率:乳糜泻患者、一级亲属和普通人群。

方法

回顾性分析,评估74例乳糜泻患者和109例非乳糜泻患者的血清学和内镜数据,后者被细分为两个亚组:有乳糜泻一级亲属的非乳糜泻患者和没有此类亲属的非乳糜泻患者。所有患者均接受实验室检查,以筛查由HLA DQ2和HLA DQ8引起的遗传敏感性。

结果

在74例乳糜泻患者中,98.4%检测到HLA DQ2和DQ8,其中79.7%仅具有HLA DQ2;8.1%仅具有HLA DQ8,10.8%同时具有两种组织相容性抗原。在乳糜泻患者的亲属组中,有29例患者;其中,89.6%具有HLA DQ2和/或DQ8;76%仅具有HLA DQ2,10.3%仅具有HLA DQ8,3.4%同时具有两种人类白细胞抗原(HLA)。

结论

HLA DQ2/DQ8在98.4%的乳糜泻患者中存在;在乳糜泻家族的亲属中为89.6%,在无乳糜泻家族史的普通人群中为55.4%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad38/4737358/03c9342703c4/0102-6720-abcd-28-03-00183-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad38/4737358/155a842f38b8/0102-6720-abcd-28-03-00183-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad38/4737358/87d3122577ee/0102-6720-abcd-28-03-00183-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad38/4737358/03c9342703c4/0102-6720-abcd-28-03-00183-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad38/4737358/155a842f38b8/0102-6720-abcd-28-03-00183-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad38/4737358/87d3122577ee/0102-6720-abcd-28-03-00183-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad38/4737358/03c9342703c4/0102-6720-abcd-28-03-00183-gf3.jpg

相似文献

1
The prevalence of HLA DQ2 and DQ8 in patients with celiac disease, in family and in general population.乳糜泻患者、其家族成员及普通人群中HLA DQ2和DQ8的患病率。
Arq Bras Cir Dig. 2015 Jul-Sep;28(3):183-5. doi: 10.1590/S0102-67202015000300009.
2
Estimation of the celiac disease prevalence in Denmark and the diagnostic value of HLA-DQ2/DQ8.丹麦的腹腔疾病患病率估计和 HLA-DQ2/DQ8 的诊断价值。
Scand J Clin Lab Invest. 2020 Dec;80(8):667-671. doi: 10.1080/00365513.2020.1829698. Epub 2020 Oct 12.
3
HLA-DQ2/DQ8 frequency in adult patients with celiac disease, their first-degree relatives, and normal population in Turkey.土耳其成年乳糜泻患者、其一级亲属及正常人群中HLA - DQ2/DQ8的频率
Turk J Gastroenterol. 2019 Apr;30(4):321-325. doi: 10.5152/tjg.2019.18255.
4
PREVALENCE OF CELIAC DISEASE PREDISPOSING GENOTYPES, INCLUDING HLA-DQ2.2 VARIANT, IN BRAZILIAN CHILDREN.巴西儿童中包括HLA-DQ2.2变体在内的乳糜泻易感基因型的患病率。
Arq Gastroenterol. 2018 Jan-Mar;55(1):82-85. doi: 10.1590/S0004-2803.201800000-16.
5
DQ2, DQ7 and DQ8 Distribution and Clinical Manifestations in Celiac Cases and Their First-Degree Relatives.乳糜泻患者及其一级亲属中DQ2、DQ7和DQ8的分布与临床表现
Nutrients. 2015 Jun 18;7(6):4955-65. doi: 10.3390/nu7064955.
6
Rapid Detection of the Three Celiac Disease Risk Genotypes HLA-DQ2.2, HLA-DQ2.5, and HLA-DQ8 by Multiplex Ligation-Dependent Probe Amplification.通过多重连接依赖探针扩增技术快速检测三种乳糜泻风险基因型HLA-DQ2.2、HLA-DQ2.5和HLA-DQ8
Genet Test Mol Biomarkers. 2016 Mar;20(3):158-61. doi: 10.1089/gtmb.2015.0233. Epub 2016 Jan 22.
7
HLA-DQ genetic risk gradient for type 1 diabetes and celiac disease in northwestern Mexico.墨西哥西北部1型糖尿病和乳糜泻的HLA - DQ基因风险梯度
Rev Gastroenterol Mex. 2015 Apr-Jun;80(2):135-43. doi: 10.1016/j.rgmx.2015.03.003. Epub 2015 Jun 16.
8
Diagnostic significance of HLA-DQ typing in patients with previous coeliac disease diagnosis based on histology alone.仅基于组织学对既往诊断为乳糜泻患者进行HLA-DQ分型的诊断意义。
Aliment Pharmacol Ther. 2006 Nov 1;24(9):1395-402. doi: 10.1111/j.1365-2036.2006.03133.x.
9
Human leukocyte antigen (HLA)-DQ2 and -DQ8 haplotypes in celiac, celiac with type 1 diabetic, and celiac suspected pediatric cases.人类白细胞抗原(HLA)-DQ2 和 -DQ8 单倍型在乳糜泻、乳糜泻合并 1 型糖尿病和乳糜泻疑似儿科病例中的研究。
Medicine (Baltimore). 2021 Mar 19;100(11):e24954. doi: 10.1097/MD.0000000000024954.
10
Frequency distribution of HLA DQ2 and DQ8 in celiac patients and first-degree relatives in Recife, northeastern Brazil.巴西东北部累西腓地区乳糜泻患者及其一级亲属中 HLA-DQ2 和 DQ8 的分布频率。
Clinics (Sao Paulo). 2011;66(2):227-31. doi: 10.1590/s1807-59322011000200008.

引用本文的文献

1
Celiac Disease-Narrative Review on Progress in Celiac Disease.乳糜泻——乳糜泻进展的叙述性综述
Foods. 2025 Mar 11;14(6):959. doi: 10.3390/foods14060959.
2
Postbiotics: As a Promising Tools in the Treatment of Celiac Disease.后生元:作为治疗乳糜泻的一种有前景的工具。
Probiotics Antimicrob Proteins. 2025 Jun;17(3):1513-1522. doi: 10.1007/s12602-024-10416-y. Epub 2024 Dec 14.
3
CD4+ T Cells From Individuals With Type 1 Diabetes Respond to a Novel Class of Deamidated Peptides Formed in Pancreatic Islets.1 型糖尿病个体中的 CD4+ T 细胞对在胰岛中形成的新型去酰胺化肽类有反应。

本文引用的文献

1
Prevalence of celiac disease in Germany: a prospective follow-up study.德国乳糜泻的患病率:一项前瞻性随访研究。
World J Gastroenterol. 2013 May 7;19(17):2612-20. doi: 10.3748/wjg.v19.i17.2612.
2
Celiac disease: early diagnosis leads to the best possible outcome.乳糜泻:早期诊断可带来最佳预后。
JAAPA. 2012 Nov;25(11):43-7. doi: 10.1097/01720610-201211000-00008.
3
Update on serologic testing in celiac disease.对乳糜泻血清学检测的最新研究进展。
Diabetes. 2024 May 1;73(5):728-742. doi: 10.2337/db23-0588.
4
Assessment of Novel Proteins Triggering Celiac Disease via Docking-Based Approach.基于对接的方法评估引发乳糜泻的新型蛋白。
Molecules. 2023 Dec 26;29(1):138. doi: 10.3390/molecules29010138.
5
A general health economics review of the hidden costs involved in discharging coeliac patients from hospital-based specialty clinics to community-based management.对乳糜泻患者从医院专科门诊出院至社区管理所涉及的隐性成本进行的一般性卫生经济学综述。
Gastroenterol Hepatol Bed Bench. 2023;16(2):173-180. doi: 10.22037/ghfbb.v16i2.2715.
6
Assessing the Prevalence of HLA-DQ2 and HLA-DQ8 in Lipedema Patients and the Potential Benefits of a Gluten-Free Diet.评估脂性水肿患者中HLA-DQ2和HLA-DQ8的患病率以及无麸质饮食的潜在益处。
Cureus. 2023 Jul 9;15(7):e41594. doi: 10.7759/cureus.41594. eCollection 2023 Jul.
7
Meta-Analysis and Systematic Review of HLA DQ2/DQ8 in Adults with Celiac Disease.Meta 分析和 HLA DQ2/DQ8 在成人乳糜泻中的系统评价。
Int J Mol Sci. 2023 Jan 7;24(2):1188. doi: 10.3390/ijms24021188.
8
Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.定义识别成人和儿童乳糜泻的最佳策略:系统评价和经济建模。
Health Technol Assess. 2022 Oct;26(44):1-310. doi: 10.3310/ZUCE8371.
9
Gut microbiome markers in subgroups of HLA class II genotyped infants signal future celiac disease in the general population: ABIS study.肠道微生物组标志物在 HLA Ⅱ类基因型婴儿亚组中预测普通人群未来的乳糜泻:ABIS 研究。
Front Cell Infect Microbiol. 2022 Jul 25;12:920735. doi: 10.3389/fcimb.2022.920735. eCollection 2022.
10
Post-Proline Cleaving Enzymes (PPCEs): Classification, Structure, Molecular Properties, and Applications.脯氨酸裂解后酶(PPCEs):分类、结构、分子特性及应用
Plants (Basel). 2022 May 18;11(10):1330. doi: 10.3390/plants11101330.
Am J Gastroenterol. 2010 Dec;105(12):2520-4. doi: 10.1038/ajg.2010.276.
4
Celiac disease: risk assessment, diagnosis, and monitoring.乳糜泻:风险评估、诊断及监测
Mol Diagn Ther. 2008;12(5):289-98. doi: 10.1007/BF03256294.
5
Celiac disease.乳糜泻
N Engl J Med. 2007 Oct 25;357(17):1731-43. doi: 10.1056/NEJMra071600.
6
[Genetics and immunopathogenics aspects of the celiac disease: a recent vision].[乳糜泻的遗传学和免疫病理学方面:最新观点]
Arq Gastroenterol. 2004 Apr-Jun;41(2):121-8. doi: 10.1590/s0004-28032004000200010. Epub 2004 Oct 27.
7
[Celiac disease: clinical characteristics and methods used in the diagnosis of patients registered at the Brazilian Celiac Association].[乳糜泻:巴西乳糜泻协会登记患者的临床特征及诊断方法]
J Pediatr (Rio J). 2001 Mar-Apr;77(2):131-8. doi: 10.2223/jped.189.
8
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study.美国高危和非高危群体中乳糜泻的患病率:一项大型多中心研究。
Arch Intern Med. 2003 Feb 10;163(3):286-92. doi: 10.1001/archinte.163.3.286.
9
Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists.乳糜泻皮肤表现的识别与管理:皮肤科医生指南
Am J Clin Dermatol. 2003;4(1):13-20. doi: 10.2165/00128071-200304010-00002.
10
[Serum antibodies in celiac disease].[乳糜泻中的血清抗体]
Arq Gastroenterol. 1999 Oct-Dec;36(4):258-64. doi: 10.1590/s0004-28031999000400014.